Data from Agios’ Phase 3 ClarIDHy Trial of TIBSOVO® Demonstrates Significant Imp
- This topic has 0 replies, 1 voice, and was last updated 4 years, 6 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
This news is just out today from ESMO in Barcelona.
Data from Agios’ Phase 3 ClarIDHy Trial of TIBSOVO® Demonstrates Significant Improvement in Progression Free Survival (PFS) Compared to Placebo in Previously Treated IDH1 Mutant Cholangiocarcinoma Patients
Gavin
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.